Concepedia

Satoshi Kubo

SK

84

Publications

3.8K

Citations

36

H-Index

1988

Active since

Affiliations

University of Occupational and Environmental Health Japan(Current)

Keio University

Hiroshima University

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Satoshi Kubo is an author at University of Occupational and Environmental Health Japan specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

1988–2025

84

Publications

84

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells

Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo et al. · Arthritis & Rheumatism · 2011 · 224 citations

Mucus sialylation determines intestinal host-commensal homeostasis

Yikun Yao, Girak Kim, Samantha Shafer et al. · Cell · 2022 · 211 citations · Full text

, , +7

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 187 citations · Full text

The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells

Satoshi Kubo, Kunihiro Yamaoka, Masahiro Kondo et al. · Annals of the Rheumatic Diseases · 2013 · 166 citations

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System

Satoshi Kubo, Shingo Nakayamada, Kei Sakata et al. · Frontiers in Immunology · 2018 · 132 citations · Full text

, , +26

Rows per page

1–5 of 84